Fms-related tyrosine kinase 3 expression discriminates hematopoietic stem cells subpopulations with differing engraftment-potential: Identifying the most potent combination

Transplantation

Volumn 85, Issue 8, 2008, Pages 1175-1184

  Huang, Yiming ^a   Ratajczak, Mariusz Z ^a   Reca, Ryan ^a   Xu, Hong ^a   Tanner, Michael ^a   Rezzoug, Francine ^a   Hussain, Lala Rukh ^a   Fugier Vivier, Isabelle ^a   Bolli, Roberto ^b   Ildstad, Suzanne T ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Flt3 ligand; Hematopoietic stem cells; Mobilization; Transplantation

Indexed keywords

ATAXIN 1; CD135 ANTIGEN; CD34 ANTIGEN; FLT3 LIGAND; GREEN FLUORESCENT PROTEIN; STEM CELL FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL ASSAY; CELL DIFFERENTIATION; CELL FUNCTION; CELL MOTILITY; CELL POPULATION; COLONY FORMING CELL; COLONY FORMING UNIT S; CONTROLLED STUDY; DOWN REGULATION; ENGRAFTMENT; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION PROTECTION;

ANIMALS; ANTIGENS, CD34; CELL DIFFERENTIATION; FMS-LIKE TYROSINE KINASE 3; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL;

EID: 42549122617     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31816a89cf     Document Type: Article

References (46)

1. Kondo M, Wagers AJ, Manz MG, et al. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu Rev Immunol 2003; 21: 759.
2. To LB, Haylock DN, Simmons PJ, et al. The biology and clinical uses of blood stem cells. Blood 1997; 89: 2233.
3. Papayannopoulou T. Hematopoietic stem/progenitor cell mobilization. A continuing quest for etiologic mechanisms. Ann N Y Acad Sci 1999; 872: 187.
4. Mueller YM, Cramer DE, Huang Y, et al. Hematopoietic stem cells from the marrow of mice treated with Flt3 ligand are significantly expanded but exhibit reduced engraftment potential. Transplantation 2002; 73: 1177.
5. Ikuta K, Weissman IL. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA 1992; 89: 1502.
6. Li CL, Johnson GR. Murine hematopoietic stem and progenitor cells. I. Enrichment and biologic characterization. Blood 1995; 85: 1472.
7. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 1988; 241: 58.
8. Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol 2001; 17: 387.
9. Osawa M, Hanada K, Hamada H, et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996; 273: 242.
10. Morrison SJ, Weissman IL. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1994; 1: 661.
11. Uchida N, Weissman IL. Searching for hematopoietic stem cells: Evidence that Thy-1.1lo Lin-Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. J Exp Med 1992; 175: 175.
12. Adolfsson J, Borge OJ, Bryder D, et al. Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 2001; 15: 659.
13. Christensen JL, Weissman IL. Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells. Proc Natl Acad Sci USA 2001; 98: 14541.
14. Yang L, Bryder D, Adolfsson J, et al. Identification of Lin(-) Sca1(+)kit(+)CD34(+)Flt3-short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood 2005; 105: 2717.
15. Lyman SD, Jacobsen SE. C-kit ligand and Flt3 ligand: Stem/progenitor cell factors with overlapping yet distinct activities. Blood 1998; 91: 1101.
16. Mackarehtschian K, Hardin JD, Moore KA, et al. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 1995; 3: 147.
17. Lyman SD, James L, Johnson L, et al. Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 1994; 83: 2795.
18. Matthews W, Jordan CT, Wiegand GW, et al. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 1991; 65: 1143.
19. Bryder D, Jacobsen SE. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood 2000; 96: 1748.
20. Neipp M, Zorina T, Domenick MA, et al. Effect of FLT3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: Kinetics and repopulating potential. Blood 1998; 92: 3177.
21. Kaufman CL, Colson YL, Wren SM, et al. Phenotypic characterization of a novel bone-marrow derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994; 84: 2436.
22. Huang Y, Rezzoug F, Chilton PM, et al. Matching at the MHC Class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: A role for host NK cells in regulating HSC engraftment. Blood 2004; 104: 873.
23. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997; 91: 661.
24. Huang Y, Rezzoug F, Xu H, et al. NK cells play a critical role in the regulation of class I-deficient hemopoietic stem cell engraftment: Evidence for NK tolerance correlates with receptor editing. J Immunol 2005; 175: 3753.
25. Xu H, Chilton PM, Huang Y, et al. Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism. J Immunol 2004; 172: 1463.
26. Chilton PM, Rezzoug F, Ratajczak MZ, et al. Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients. Blood 2005; 105: 2189.
27. Okada S, Nakauchi H, Nagayoshi K, et al. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 1991; 78: 1706.
28. Katayama N, Shih JP, Nishikawa S, et al. Stage-specific expression of c-kit protein by murine hematopoietic progenitors. Blood 1993; 82: 2353.
29. Kawashima I, Zanjani ED, Maida-Porada G, et al. CD34+ human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. Blood 1996; 87: 4136.
30. Small D, Levenstein M, Kim E, et al. STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 1994; 91: 459.
31. Grimes HL, Schanie CL, Huang Y, et al. Graft facilitating cells are derived from hematopoietic stem cells and functionally require CD3, but are distinct from T lymphocytes. Exp Hematol 2004; 32: 946.
32. Jones RJ, Wagner JE, Celano P, et al. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature 1990; 347: 188.
33. Nakauchi H, Takano H, Ema H, et al. Further characterization of CD34-low/negative mouse hematopoietic stem cells. Ann N Y Acad Sci 1999; 872: 57.
34. Zhao Y, Lin Y, Zhan Y, et al. Murine hematopoietic stem cell characterization and its regulation in BM transplantation. Blood 2000; 96: 3016.
35. Na NT, Traver D, Weissman IL, et al. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J Clin Invest 2002; 109: 1579.
36. Adolfsson J, Mansson R, Buza-Vidas N, et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 2005; 121: 295.
37. Jansen J, Hanks S, Thompson JM, et al. Transplantation of hematopoietic stem cells from the peripheral blood. J Cell Mol Med 2005; 9: 37.
38. Antonysamy MA, Thomson AW. Flt3 ligand (FL) and its influence on immune reactivity. Cytokine 2000; 12: 87.
39. Fugier-Vivier I, Rezzoug F, Huang Y, et al. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J Exp Med 2005; 201: 373.
40. Jones RJ, Collector MI, Barber JP, et al. Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood 1996; 88: 487.
41. Doi H, Inaba M, Yamamoto Y, et al. Pluripotent hemopoietic stem cells are c-kit
42. Hodgson GS, Bradley TR. Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: Evidence for a pre-CFU-S cell? Nature 1979; 281: 381.
43. Rosendaal M, Hodgson GS, Bradley TR. Haemopoietic stem cells are organised for use on the basis of their generation-age. Nature 1976; 264: 68.
44. Zeigler FC, Bennett BD, Jordan CT, et al. Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells. Blood 1994; 84: 2422.
45. Lyman SD, James L, Vanden Bos T, et al. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 1993; 75: 1157.
46. Rossi DJ, Bryder D, Zahn JM, et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA 2005; 102: 9194.